ArticleIJID regions2025
A step forward in tuberculosis elimination: implementing migrant latent tuberculosis screening and treatment in Oman.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- What is the Impact of Risk Factors on Communicable Diseases among Migrant Workers in the Gulf Cooperation Council: a Systematic Review.Journal of epidemiology and global health · 2025Pooled it
- The Evolution of EBS in Oman: From Planning Stages to Practical Application.Journal of epidemiology and global health · 2026Article
- Ending tuberculosis in Gulf Cooperation Council countries: an overview of the WHO End TB Strategy 2025 milestones.IJID regions · 2025Review
- Health Service Contracting in the Prevention and Treatment of Tuberculosis: A Scoping Review.Journal of multidisciplinary healthcare · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to outline the process of implementation of latent tuberculosis (TB) infection (LTBI) screening among migrants using interferon-γ release assay (IGRA), describe the LTBI treatment protocol and cascade of care, and highlight success factors and challenges. Design: This is a description of the process of implementation of screening of TB infection through a medical fitness program for residency, using primary care treatment module and short regimen. Results: Before 2018, expatriates seeking residency employment in Oman undergo two-step medical fitness examination process that mainly rely on chest X-ray (CXR) before arrival and physical examination after arrival, with 15% random sample repeated. In 2018, Oman implemented CXR screening for all alongside symptom checks. With further surge of TB cases after COVID-19, screening using IGRA was introduced through a medical fitness program in 2024. Those who are IGRA-positive or indeterminate will proceed to CXR with subsequent referral to primary care for short regimen treatment (3 months of daily rifampicin plus isoniazid and pyridoxine) if eligible. Conclusions: Oman aims to achieve sustainability through establishing an integrated LTBI screening for migrants within the residency medical fitness program using integrated electronic system, highly sensitive test, public private model (under government regulation), and high throughput testing methods. Treatment using a short regimen (3 months of daily rifampicin plus isoniazid) through primary care will improve treatment adherence, improve outcome, and reduce TB incidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.